Comparative Study of Biologic Mesh Versus Repair With Component Separation. (Davol)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare open abdominal incisional hernia repair using XenMATRIX biologic mesh versus repair with their own tissue. This study will provide information in determining if a biological mesh is necessary to provide a sturdy repair for a ventral hernia.
| Condition | Intervention | Phase |
|---|---|---|
|
Ventral Hernia |
Device: XenMATRIX mesh Procedure: Open abdominal ventral hernia repair |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | Randomized Control Trial of Biologic Mesh (XenMATRIXTM) vs. Component Separation Alone in Contaminated Ventral Hernia Repair:a Pilot Study |
- The incidence of postoperative hernia recurrence [ Time Frame: two years after surgery date ] [ Designated as safety issue: No ]
- Compare the short-term clinical outcomes of postoperative wound events [ Time Frame: two years after surgery date ] [ Designated as safety issue: No ]
- Length of hospital stay [ Time Frame: Number of days up to 1 week ] [ Designated as safety issue: No ]Participants will be followed for the duration of the hospital stay, an expected average of 1 week
- Length of resource utilization [ Time Frame: two years after surgery date ] [ Designated as safety issue: No ]
- Antibiotic usage and days [ Time Frame: two years after surgery date ] [ Designated as safety issue: No ]
- Resumption of Activities of Daily Living [ Time Frame: two years after surgery date ] [ Designated as safety issue: No ]
| Enrollment: | 9 |
| Study Start Date: | January 2011 |
| Study Completion Date: | May 2012 |
| Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: XenMATRIX
Use of XenMATRIX mesh to repair hernia
|
Device: XenMATRIX mesh
Use of XenMATRIX mesh in the repair of contaminated ventral hernia repair
Other Name: Davol Biologic mesh
|
|
Active Comparator: Native tissue
Repair with participants native tissue
|
Procedure: Open abdominal ventral hernia repair
Abdominal ventral hernia repair with native tissue
Other Name: Abdominal ventral hernia repair with native tissue
|
Detailed Description:
This study will involve comparison of open abdominal incisional hernia repair with XenMATRIX biologic graft versus repair with native tissue.
The current study seeks to evaluate XenMATRIXTM, an FDA approved biologic graft for repairing contaminated abdominal wall defects.
This study will provide significant insight for the reconstructive surgeon and patient to determine whether a biologic graft is necessary for the reconstruction of a contaminated ventral hernia repair to provide a durable single staged repair.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Is an adult ≥ 18 years old of either gender
- Will undergo a planned open abdominal incisional hernia repair
- Has a defect that can be repaired primarily without tension with myofascial advancement flaps and requires no more than 1 piece of surgical mesh (largest mesh size (19 x 35 cm)
- Contamination is known preoperatively, e.g. repair in the presence of a chronic wound, the presence of a stoma or in conjunction with a bowel resection, or such contaminations occurs intraoperatively, e.g. inadvertent enterotomy or opening of other hollow intra-abdominal viscus
- Infection is known due to local frank signs of incisional drainage, fistula formation or abdominal abscess following prior surgical abdominal surgery or presence of infected mesh
- Has an estimated hernia size of ≥ 3cm to 20cm in maximal width by physical exam
- Is considered a clean-contaminated or contaminated case per Surgical Site Infection Risk Guidelines
- Is willing and able to return for all scheduled and required study visits
- Is willing and able to provide written informed consent for study participation
Exclusion Criteria:
- Has a defect that the surgeon cannot achieve primary fascial apposition and requires a bridge of mesh
- Is a clean or dirty case per Surgical Site Infection Risk Guidelines
- Has conditions that would adversely affect subject safety as per product labeling
- Will undergo a laparoscopic hernia repair
- Has a nidus of chronic colonization, such as chronic indwelling bladder catheter or significant amounts of non-removable infected mesh
- Has conditions which preclude abdominal imaging at a standard imaging facility
- Has an anticipated survival of < 24 months
- Care plan is to perform a staged repair over 45 days
- Is bedridden or otherwise non-ambulatory (i.e. is unable to independently transfer into and out of a wheelchair)
- Is ASA class 4 or 5
- BMI over 45
- Is pregnant
Contacts and Locations| United States, Ohio | |
| University Hospitals Case Medical Center | |
| Cleveland, Ohio, United States, 44106 | |
| Principal Investigator: | Michael J. Rosen, MD. | University Hospitals of Cleveland Case Medical Center |
More Information
No publications provided
| Responsible Party: | Michael J. Rosen, MD., Principal Investigator, University Hospitals of Cleveland |
| ClinicalTrials.gov Identifier: | NCT01295125 History of Changes |
| Other Study ID Numbers: | 11-10-23 |
| Study First Received: | February 11, 2011 |
| Last Updated: | June 25, 2012 |
| Health Authority: | United States: Institutional Review Board United States: Federal Government United States: Food and Drug Administration |
Keywords provided by University Hospitals of Cleveland:
|
Infected ventral hernia Contaminated incisional hernia |
Additional relevant MeSH terms:
|
Hernia Hernia, Ventral Pathological Conditions, Anatomical Hernia, Abdominal |
ClinicalTrials.gov processed this record on May 23, 2013